genOway
Designs and develops genetically modified preclinical models for research.
ALGEN | PA
Overview
Corporate Details
- ISIN(s):
- FR0004053510
- LEI:
- 969500HMHUPR3KYXUT19
- Country:
- France
- Address:
- 31 RUE SAINT JEAN DE DIEU, 69007 LYON
- Website:
- https://www.genoway.com
Description
genOway is a biotechnology company that specializes in designing and developing genetically modified preclinical models. It provides biopharmaceutical companies and academic researchers with genetically engineered mouse, rat, and cell line models intended to improve the predictability of preclinical research. The company's portfolio includes a catalog of off-the-shelf models as well as customized model creation services. Key areas of application for its models include immuno-oncology and pharmacokinetic (PK) analysis, featuring a range of humanized models. genOway emphasizes a collaborative approach, providing scientifically validated solutions to support the development of new therapies for clinical trials.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-12-07 18:00 |
Agenda financier 2022
|
French | 16.0 KB | ||
| 2021-11-16 17:45 |
genOway accélère son développement sur le marché des modèles cellulaires : sign…
|
French | 118.1 KB | ||
| 2021-10-25 17:45 |
genOway a finalisé la conception du 1er modèle de recherche permettant de repro…
|
French | 164.4 KB | ||
| 2021-09-27 17:45 |
Résultats du 1er semestre 2021
|
French | 185.4 KB | ||
| 2021-07-19 18:05 |
Accélération de la croissance semestrielle à +30%, tirée par la forte progressi…
|
French | 183.1 KB | ||
| 2021-05-27 18:00 |
genOway réalise une levée de fonds de 5,6 M EUR au prix de 4 EUR pour financer …
|
French | 273.1 KB | ||
| 2021-05-06 18:15 |
Projet d'augmentation de capital d'environ 5 M EUR par placement privé au prix …
|
French | 92.8 KB | ||
| 2021-03-30 17:45 |
Résultats annuels 2020 : une démonstration de la validité du nouveau plan strat…
|
French | 179.8 KB | ||
| 2021-01-26 17:45 |
Après les États-Unis, délivrance d'un 1er brevet européen pour la technologie S…
|
French | 132.0 KB | ||
| 2021-01-19 18:00 |
Chiffre d'affaires 2020 en croissance organique de 16% : 1er objectif de croiss…
|
French | 164.9 KB | ||
| 2021-01-05 17:45 |
genOway obtient une subvention 2,3 M EUR de l'Union européenne et de la Région …
|
French | 143.5 KB | ||
| 2020-10-09 10:30 |
Prix Nobel de Chimie pour la découverte du système CRISPR/Cas9
|
French | 91.0 KB | ||
| 2020-09-17 17:45 |
Résultats du 1er semestre 2020
|
French | 191.2 KB | ||
| 2020-07-16 17:45 |
Progression de +20% du chiffre d'affaires au 1er semestre 2020
|
French | 160.3 KB | ||
| 2020-06-30 07:30 |
genOway investit dans un nouveau laboratoire pour produire ses modèles immunodé…
|
French | 162.0 KB |
Automate Your Workflow. Get a real-time feed of all genOway filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for genOway
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for genOway via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-01-17 | N/A | Other | Sell | 1,700 | 8,160.00 EUR |
| 2023-12-15 | N/A | Other | Sell | 5,000 | 22,000.00 EUR |
| 2023-11-23 | N/A | Other | Sell | 500 | 2,100.00 EUR |
| 2023-10-23 | N/A | Other | Sell | 100 | 390.00 EUR |
| 2023-09-25 | N/A | Other | Buy | 5,000 | 20,000.00 EUR |
| 2023-05-04 | N/A | Other | Buy | 60,000 | 222,000.00 EUR |
| 2023-05-02 | N/A | Other | Sell | 20,000 | 74,000.00 EUR |
Peer Companies
